Does the absence of ABCC6 (multidrug resistance protein 6) in patients with Pseudoxanthoma elasticum prevent the liver from providing sufficient vitamin K to the periphery?

Cell Cycle

Volumn 7, Issue 11, 2008, Pages 1575-1579

  Borst, Piet ^a   Van De Wetering, Koen ^a   Schlingemann, Reinier ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

ABC transporters; ABCC6; Glutathione; Menadione; MRP6; Pseudoxanthoma elasticum; Vitamin K

Indexed keywords

ABCC6 PROTEIN; ANTIVITAMIN K; GLUCURONIDE; GLUTATHIONE; MENADIONE; MULTIDRUG RESISTANCE PROTEIN 6; VITAMIN K DEPENDENT CARBOXYLASE; VITAMIN K GROUP;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DISEASE; AUTOSOMAL RECESSIVE INHERITANCE; BASOLATERAL MEMBRANE; CALCIFICATION; CARBOXYLATION; CONNECTIVE TISSUE; CONTROLLED STUDY; EYE DISEASE; METABOLIC DISORDER; MINERALIZATION; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOXANTHOMA ELASTICUM; RAT; REVIEW; SKIN DISEASE; SYMPTOMATOLOGY;

MUS; RATTUS;

EID: 45849111436     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.7.11.6005     Document Type: Review

References (43)

1. Neldner KH. Pseudoxanthoma elasticum. Clin Dermatol 1988; 6:1-159.
2. Le Saux O, Urban Z, Tschuch C, Csiszar K, Bacchelli B, Quaglino D, Pasquali Ronchetti I, Pope FM, Richards A, Terry S, Bercovitch L, de Paepe A, Boyd CD. Mutations in a gene encoding an ABC transporter cause Pseudoxanthoma elasticum. Nat Genet 2000; 25:223-7.
3. Bergen AA, Plomp AS, Schuurman EJ, Terry S, Breuning M, Dauwerse H, Swart J, Kool M, van Soest S, Baas F, ten Brink JB, de Jong PT. Mutations in ABCC6 cause Pseudoxanthoma elasticum. Nat Genet 2000; 25:228-31.
4. Ringpfeil F, Lebwohl MG, Christiano AM, Uitto J. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci USA 2000; 97:6001-6.
5. Gorgels TG, Hu X, Scheffer GL, van der Wal AC, Toonstra J, de Jong PT, van Kuppevelt TH, Levelt CN, de Wolf A, Loves WJ, Scheper RJ, Peek R, Bergen AA. Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum. Hum Mol Genet 2005; 14:1763-73.
6. Klement JF, Matsuzaki Y, Jiang QJ, Terlizzi J, Choi HY, Fujimoto N, Li K, Pulkkinen l, Birk DE, Sundberg JP, Uitto J. Targeted ablation of the abcc6 gene results in ectopic mineralization of connective tissues. Mol Cell Biol 2005; 25:8299-310.
7. Haimeur A, Conseil G, Deeley RG, Cole SP. The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation. Curr Drug Metab 2004; 5:21-53.
8. Borst P, Oude Elferink R. Mammalian ABC transporters in health and disease. In: Richardson CC, Kornberg R, Raetz CHR, Thorstensen K, eds. Ann Rev Biochem California: Science 2002; 537-92.
9. Belinsky MG, Chen ZS, Shchaveleva I, Zeng H, Kruh GD. Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6). Cancer Res 2002; 62:6172-7.
10. Ilias A, Urban Z, Seidl TL, Le Saux O, Sinko E, Boyd CD, Sarkadi B, Varadi A. Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6). J Biol Chem 2002; 277:16860-7.
11. Scheffer GL, Hu X, Pijnenborg AC, Wijnholds J, Bergen AA, Scheper RJ. MRP6 (ABCC6) detection in normal human tissues and tumors. Lab Invest 2002; 82:515-8.
12. Beck K, Hayashi K, Nishiguchi B, Le Saux O, Hayashi M, Boyd CD. The distribution of Abcc6 in normal mouse tissues suggests multiple functions for this ABC transporter. J Histochem Cytochem 2003; 51:887-902.
13. Beck K, Hayashi K, Dang K, Hayashi M, Boyd CD. Analysis of ABCC6 (MRP6) in normal human tissues. Histochem Cell Biol 2005; 123:517-28.
14. Hu X, Peek R, Plomp A, ten Brink J, Scheffer G, van Soest S, Leys A, de Jong PT, Bergen AA. Analysis of the frequent R1141X mutation in the ABCC6 gene in pseudoxanthoma elasticum. Invest Ophthalmol Vis Sci 2003; 44:1824-9.
15. Gheduzzi D, Boraldi F, Annovi G, DeVincenzi CP, Schurgers LJ, Vermeer C, Quaglino D, Ronchetti IP. Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients. Lab Invest 2007; 87:998-1008.
16. Uitto J, Jiang Q. Pseudoxanthoma elasticum-like phenotypes: more diseases than one. J Invest Dermatol 2007; 127:507-10.
17. Uitto J, Pulkkinen l, Ringpfeil F. Molecular genetics of Pseudoxanthoma elasticum: a metabolic disorder at the environment-genome interface? Trends Molecular Medicine 2001;7:13-7.
18. Jiang Q, Endo M, Udagawa N, Li Q, Uitto J. Aberrant mineralization of connective tissues in Pseudoxanthoma elasticum: A mouse grafting model. J Invest Dermatol 2008; 127.
19. Jiang Q, Dibra F, Wang K, Uitto J. Cell-based therapy for Pseudoxanthoma elasticum: reduction of connective tissue mineralization in a mouse model (Abcc6-/-) by transplantation of wild-type hepatocytes. J Invest Dermatol 2008.
20. Vanakker OM, Martin L, Gheduzzi D, Leroy BP, Loeys BL, Guerci VI, Matthys D, Terry SF, Coucke PJ, Pasquali Ronchetti I, de Paepe A. Pseudoxanthoma elasticum-like phenotype with cutis laxa and multiple coagulation factor deficiency represents a separate genetic entity. J Invest Dermatol 2007; 127:581-7.
21. Cranenburg EC, Schurgers LJ, Vermeer C. Vitamin K: the coagulation vitamin that became omnipotent. Thromb Haemost 2007; 98:120-5.
22. Schurgers LJ, Teunissen KJ, Knapen MH, Kwaijtaal M, van Diest R, Appels A, Reutelingsperger CP, Cleutjens JP, Vermeer C. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification. Arterioscler Thromb Vasc Biol 2005; 25:1629-33.
23. Schurgers LJ, Spronk HM, Skepper JN, Hackeng TM, Shanahan CM, Vermeer C, Weissberg PL, Proudfoot D. Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost 2007; 5:2503-11.
24. Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood 2007; 109:2823-31.
25. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386:78-81.
26. Schurgers LJ, Teunissen KJ, Hamulyak K, Knapen MH, Vik H, Vermeer C. Vitamin Kcontaining dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007; 109:3279-83.
27. Spronk HM, Soute BA, Schurgers LJ, Thijssen HH, De Mey JG, Vermeer C. Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarintreated rats. J Vasc Res 2003; 40:531-7.
28. Jiang Q, Li Q, Uitto J. Aberrant mineralization of connective tissues in a mouse model of pseudoxanthoma elasticum: systemic and local regulatory factors. J Invest Dermatol 2007; 127:1392-402.
29. -/-). Biochem Biophys Res Commun 2007; 364:208-13.
30. Shearer MJ, Bach A, Kohlmeier M. Chemistry, nutritional sources, tissue distribution and metabolism of vitamin K with special reference to bone health. J Nutr 1996; 126:1181-6.
31. Shearer MJ, Newman P. Metabolism and cell biology of vitamin K. Thromb Haemost 2008; (in press).
32. Yamamoto R, Komai M, Kojima K, Furukawa Y, Kimura S. Menaquinone-4 accumulation in various tissues after an oral administration of phylloquinone in Wistar rats. J Nutr Sci Vitaminol (Tokyo) 1997; 43:133-43.
33. Thijssen HH, Vervoort LM, Schurgers LJ, Shearer MJ. Menadione is a metabolite of oral vitamin K. Br J Nutr 2006; 95:260-6.
34. Okano T, Shimomura Y, Yamane M, Suhara Y, Kamao M, Sugiura M, Nakagawa K. Conversion of phylloquinone (vitamin K1) into menaquinone-4 (vitamin K2) in mice: Two possible routes for menaquinone-4 accumulation in cerebra of mice. J Biol Chem 2007; (in press).
35. Losito R, Owen CA Jr, Flock EV. Metabolic studies of vitamin K1-14C and menadione-14C in the normal and hepatectomized rats. Thromb Diath Haemorrh 1968; 19:383-8.
36. Suhara Y, Murakami A, Nakagawa K, Mizuguchi Y, Okano T. Comparative uptake, metabolism, and utilization of menaquinone-4 and phylloquinone in human cultured cell lines. Bioorg Med Chem 2006; 14:6601-7.
37. Losito R, Owen CA Jr, Flock EV. Metabolism of [14C]menadione. Biochem 1967; 6:62-8.
38. Akerboom T, Bultmann T, Sies H. Inhibition of biliary taurocholate excretion during menadione metabolism in perfused rat liver. Arch Biochem Biophys 1988; 263:10-8.
39. Harrington DJ, Booth SL, Card DJ, Shearer MJ. Excretion of the urinary 5C- and 7C-aglycone metabolites of vitamin K by young adults responds to changes in dietary phylloquinone and dihydrophylloquinone intakes. J Nutr 2007; 137:1763-8.
40. Di Monte D, Ross D, Bellomo G, Eklow L, Orrenius S. Alterations in intracellular thiol homeostasis during the metabolism of menadione by isolated rat hepatocytes. Arch Biochem Biophys 1984; 235:334-42.
41. Borst P, Zelcer N, Van de Wetering K, Poolman B. On the putative co-transport of drugs by multidrug resistance proteins. FEBS Letters 2006; 580:1085-93.
42. Van de Wetering K, Zelcer N, Kuil A, Feddema W, Hillebrand M, Vlaming ML, Schinkel AH, Beijnen JH, Borst P. Multidrug resistance proteins 2 and 3 provide alternative routes for hepatic excretion of morphine-glucuronides. Mol Pharmacol 2007; 72:387-94.
43. Li Q, Jiang Q, LaRusso J, Klement JF, Sartorelli AC, Belinsky MG, Kruh GD, Uitto J. Targeted ablation of Abcc1 or Abcc3 in Abcc6(-/-) mice does not modify the ectopic mineralization process. Exp Dermatol 2007; 16:853-9.